Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

Clinical trial NCT00726544 · TERMINATED

Trial details

NCT number: NCT00726544
Sponsor: Archemix Corp.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombotic Microangiopathy Thrombotic Thrombocytopenic Purpura

Start date: 2008-12-01
Primary completion: 2010-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.